Insights

BioEconomy growth Forbion is expanding beyond traditional biotech funding into the BioEconomy Fund I focused on sustainable, biology-based industrial solutions. This signals sales opportunities with portfolio companies and potential LPs in sustainability tech, biomaterials, and environmental technologies.

Planetary health focus Leadership emphasizes planetary health strategy with Joy Faucher joining as General Partner to co-lead this area. This creates a clear entry point for partnerships around sustainable agriculture, food tech, and environmental solutions.

Fundraising momentum Recent financing for the BioEconomy Fund and high-profile exits/rounds by portfolio companies indicate strong fundraising and growth trajectory, suggesting opportunities for co-investments, fund-of-fund relationships, and advisory services.

Strategic portfolio Active investments across seed to Series A in biotech and biomaterials (Seamless Therapeutics, LoQus23, Pact, EEDEN) demonstrate a readiness to collaborate on early-stage biotech and sustainability tech deals, offering partnership and acceleration opportunities.

Tech-enabled scale Utilization of modern tech stack (AWS, Microsoft 365 Copilot, DocuSign, Greenhouse, etc.) alongside growth in digital outreach suggests readiness for vendor partnerships, AI-enabled due diligence, and operational efficiency services for portfolio management and deal sourcing.

Similar companies to Forbion

Forbion Tech Stack

Forbion uses 8 technology products and services including Amazon Web Services, Microsoft 365 Copilot, Amazon Simple Email Service, and more. Explore Forbion's tech stack below.

Media & News

Forbion's Email Address Formats

Forbion uses at least 4 email formats:
Forbion Email FormatsExamplePercentage
First.Last@forbion.comJohn.Doe@forbion.com
82%
First.Middle.Last@forbion.comJohn.Michael.Doe@forbion.com
9%
FLast@forbion.comJDoe@forbion.com
7%
Last@forbion.comDoe@forbion.com
2%

Frequently Asked Questions

What is Forbion's stock symbol?

Minus sign iconPlus sign icon
Forbion is a publicly traded company; the company's stock symbol is FRBNW.

What is Forbion's official website and social media links?

Minus sign iconPlus sign icon
Forbion's official website is forbion.com and has social profiles on LinkedIn.

How much revenue does Forbion generate?

Minus sign iconPlus sign icon
As of October 2026, Forbion's annual revenue is estimated to be $10M - $25M.

What is Forbion's SIC code and NAICS code?

Minus sign iconPlus sign icon
Forbion's SIC code is 6371 - Pension, Health, and Welfare Funds and NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Forbion have currently?

Minus sign iconPlus sign icon
As of October 2026, Forbion has approximately 98 employees across 3 continents, including Europe, North America and Asia. Key team members include Chief Legal, Risk & Compliance Officer: M. G., Chief Accounting Officer: W. K. and Vice President Finance: J. F. Explore Forbion's employee directory with LeadIQ.

What industry does Forbion belong to?

Minus sign iconPlus sign icon
Forbion operates in the Venture Capital and Private Equity Principals industry.

What technology does Forbion use?

Minus sign iconPlus sign icon
Forbion's tech stack includes Amazon Web Services, Microsoft 365 Copilot, Amazon Simple Email Service, Mailchimp, Zapier, DocuSign, Greenhouse and Vimeo.

What is Forbion's email format?

Minus sign iconPlus sign icon
Forbion's email format typically follows the pattern of First.Last@forbion.com. Find more Forbion email formats with LeadIQ.

When was Forbion founded?

Minus sign iconPlus sign icon
Forbion was founded in 2006.
Forbion logo

Forbion

Venture Capital and Private Equity PrincipalsNorth Holland, Netherlands51-200 Employees

Forbion is a global venture capital firm with deep expertise in Europe, supporting innovative biotechnology companies across all stages of pharmaceutical drug development. Based in Naarden, North Holland, Netherlands, the firm operates a platform that uses multiple strategies to back biotech ventures throughout their development trajectory. Its work is grounded in scientific and clinical progress, focusing on translating research into therapies while applying biotech know-how to broader planetary health challenges when relevant.

Beyond its traditional biotech focus, Forbion runs a BioEconomy strategy aimed at backing companies developing biology-based solutions in food, agriculture, materials, and environmental technologies. The firm has appointed Joy Faucher as General Partner to lead and expand the BioEconomy and planetary health agenda. This alignment places Forbion at the intersection of therapeutic biotech and sustainability-focused biotechnologies within its European ambit.

Section iconCompany Overview

SIC Code
6371 - Pension, Health, and Welfare Funds
Stock Symbol
FRBNW
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    Forbion's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.